Create Alert
Watchlist

Akums Drugs & Pharmaceuticals

₹423.05
-7.40 (1.72%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
430.60
Prev. Close
430.45
Volume
1,67,310
Total traded value
7.08 Cr
Upper Circuit
465.35
Lower Circuit
380.75

Fundamentals

Market Cap₹6,662Cr
ROE10.07%
P/E Ratio(TTM)20.61
EPS(TTM)20.54
P/B Ratio2.12
Dividend Yield0.00%
Industry P/E33.26
Book Value200.11
Debt to Equity0.03
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Akums Drugs And Pharmaceuticals

Established in 2004, Akums Drugs & Pharmaceuticals Limited is the largest Contract Development and Manufacturing Organisation (CDMO) with a focus on the Indian pharmaceutical market. Its vision is to become a globally admired pharmaceutical organization by providing affordable and research-based quality products to a wide global population. The company's mission is to contribute to humanity's quest for longer, healthier, and happier lives by offering innovative healthcare products. Akums specializes in end-to-end solutions for pharmaceuticals, nutraceuticals, herbal products, and cosmetics, covering development to commercialization and regulatory compliance. Beyond its core contract manufacturing business, the company also markets its own branded formulations in both Indian and international markets. The company operates 14 state-of-the-art manufacturing facilities, which are certified by global regulatory bodies such as WHO-GMP and USFDA.;
Parent OrganisationAkums Drugs And Pharmaceuticals
Managing DirectorSanjeev Jain, Sandeep Jain
Founded2004
NSE SymbolAKUMS

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
75.26%
Retail And Others
13.19%
Mutual Funds
6.44%
Other Domestic Institutions
2.84%
Foreign Institutions
2.28%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.25
Emcure Pharmaceuticals
NA
(0.00%)
33.30
Wockhardt
NA
(0.00%)
-427.29
Cohance Lifesciences
NA
(0.00%)
65.51
2025
13
Nov
Quarterly Result
Release date
8
Aug
Quarterly Result
Release date
26
May
Quarterly & Annual Result
Release date
6
Feb
Quarterly Result
Release date
2024
9
Nov
Quarterly Result
Release date
24
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks